Glucose lowering drugs or strategies, major adverse cardiovascular events and heart failure outcomes, and association with weight loss - meta-analysis of large cardiovascular outcome trials
Event:
ESC Congress 2019
Topic:
Diabetes and the Heart
Session:
Progress in secondary prevention - New treatments